Active Immunotherapy by B.C.G.
Immunotherapy is a new method of killing malignant cells in the treatment of cancer. It is well known, from the rejection of incompatible grafts, that membrane antigens can excite an immune reaction capable of killing cells carrying these antigens. It is also known that these immune reactions can sometimes fail to kill the cells that have raised the reaction and, indeed, work quite to the contrary by protecting the cells: this is the enhancement phenomenon (1).
KeywordsAcute Lymphoblastic Leukaemia Leukaemic Cell Active Immunotherapy Active Specific Immunotherapy Methyl Hydrazine
Unable to display preview. Download preview PDF.
- 7.Biozzi, G., C. Stiffel, B.N. Halpern and D. Mouton. C.R. Soc. Biol., 153:987, 1959.Google Scholar
- 8.Amiel, J.L. and M. Bérardet. Rev. franç. Etudes clin, biol., 14:587, 1969.Google Scholar
- 12.Amiel, J.L. and M. Bérardet, Europ. J. Cancer, 6: in press, 1970.Google Scholar
- 15.Yoshida T.O. and K. Imai, Europ. J. clin. biol. Res., 15:61, 1970.Google Scholar
- 18.Mathé, G., J.L. Amiel, L. Schwarzenberg, M. Schneider, A. Cattan, M. Hayat, F. de Vassal and J.R. Schlumberger, p. 109 in “Advances in the treatment of Acute (blastic) leukaemias”, 1 vol. (G. Mathé ed.) Recent Results in Cancer Res., Heidelberg, 1970, Springer-Verlag.Google Scholar
- 19.Holland J.F. and O. Glidewell, p. 95 in “Advances in the treatment of Acute (blastic) leukaemia” 1 vol. (G. Mathé ed.) Recent results in cancer research, Heidelberg, 1970, Springer Verlag.Google Scholar
- 21.Bredt, A.B. and M.R. Mardiney, Transplantation, 8:763, 1969.Google Scholar
- 22.Mathé, G., J.L. Amiel, L. Schwarzenberg, M. Schneider, M. Hayat, F. de Vassal, C. Jasmin, C. Rosenfeld, M. Sakouhi, and J. Choay, Europ. J. clin. biol. Res., 15:671, 1970.Google Scholar